DAURIANA Trademark

Trademark Overview


On Tuesday, June 5, 2018, a trademark application was filed for DAURIANA with the United States Patent and Trademark Office. The USPTO has given the DAURIANA trademark a serial number of 87948667. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 31, 2022. This trademark is owned by Pfizer Inc.. The DAURIANA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use
dauriana

General Information


Serial Number87948667
Word MarkDAURIANA
Filing DateTuesday, June 5, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 31, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 30, 2018

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 11, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Monday, January 31, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 31, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, June 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 17, 2021EXTENSION 5 GRANTED
Friday, June 11, 2021EXTENSION 5 FILED
Thursday, June 17, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 11, 2021TEAS EXTENSION RECEIVED
Saturday, November 21, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 19, 2020EXTENSION 4 GRANTED
Thursday, November 19, 2020EXTENSION 4 FILED
Thursday, November 19, 2020TEAS EXTENSION RECEIVED
Wednesday, June 10, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 8, 2020EXTENSION 3 GRANTED
Monday, June 8, 2020EXTENSION 3 FILED
Monday, June 8, 2020TEAS EXTENSION RECEIVED
Wednesday, December 4, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 2, 2019EXTENSION 2 GRANTED
Monday, December 2, 2019EXTENSION 2 FILED
Monday, December 2, 2019TEAS EXTENSION RECEIVED
Wednesday, June 5, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 3, 2019EXTENSION 1 GRANTED
Monday, June 3, 2019EXTENSION 1 FILED
Monday, June 3, 2019TEAS EXTENSION RECEIVED
Tuesday, December 25, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 30, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 30, 2018PUBLISHED FOR OPPOSITION
Wednesday, October 10, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 20, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 19, 2018ASSIGNED TO EXAMINER
Monday, June 11, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, June 8, 2018NEW APPLICATION ENTERED IN TRAM